Ghrelin concentration is correlated with IGF-I/IGFBP-3 molar ratio but not with GH secretion in children with short stature

被引:0
|
作者
Stawerska, Renata [1 ,2 ]
Smycznska, Joanna [1 ,2 ]
Czkwianianc, Elzbieta [3 ]
Pisarek, Hanna [4 ]
Hilczer, Maciej [1 ,2 ]
Lewinski, Andrzej [1 ,5 ]
机构
[1] Polish Mothers Mem Hosp, Res Inst, Dept Endocrinol & Metab Dis, PL-93338 Lodz, Poland
[2] Med Univ Lodz, Dept Pediat Endocrinol, Lodz, Poland
[3] Polish Mothers Mem Hosp, Res Inst, Dept Gastroenterol & Pediat, Lodz, Poland
[4] Med Univ Lodz, Dept Pediat Endocrinol, Lodz, Poland
[5] Med Univ Lodz, Dept Endocrinol & Metab Dis, Lodz, Poland
关键词
ghrelin; insulin-like growth factor type I; insulin-like growth factors binding protein-3; growth hormone deficiency; neurosecretory dysfunction; idiopathic short stature; children; IGF-I; SERUM GHRELIN; GROWTH; PROTEIN-3; IGFBP-3;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES: In children with growth hormone deficiency (GHD) and neurosecretory dysfunction (NSD) ghrelin concentrations are significantly higher than in children with idiopathic short stature (ISS), however the correlation between serum ghrelin and growth hormone (GH) is not observed. The aim of the study was to compare ghrelin concentrations with IGF-I/IGFBP3 molar ratio in children with short stature due to different etiology. MATERIAL: Analysis comprised 136 children (58 girls and 78 boys), aged 3.86-16.82 years with short stature (below -2.0 SD); in 21 of them GHD was diagnosed, in 23 - NSD and 92 - ISS. In each child, fasting ghrelin, insulin-like growth factor type I (IGF-I) and its binding protein type 3 (IGFBP-3) concentrations were measured. The results were analysed separately in younger and in older children. Depending on IGF-I/IGFBP-3 molar ratio, children were divided into two (2) groups: with lower IGF-I/IGFBP-3 and with higher IGF-I/IGFBP-3 ratio value. RESULTS: Both in younger and in the older age groups, ghrelin concentration was significantly higher in children with lower IGF-I/IGFBP-3 ratio than in children with higher IGF-I/IGFBP-3 value (1937.3 +/- 1232.4 vs 1365.3 +/- 632.1 pg/ml in younger children and 1205.4 +/- 548.8 vs 867.4 +/- 282.9 pg/ml in older children). The negative correlation between ghrelin and IGF-I/IGFBP-3 ratio was observed in both age groups. Not only children with GHD and NSD, but also as much as 39% out of all children with ISS were qualified into the subgroups with lower IGF-I/IGFBP-3 ratio. CONCLUSIONS: Ghrelin secretion is elevated in children with lower IGF-I/IGFBP-3 ratio. It seems that lower bioactivity of IGF-I is stimulating factor for ghrelin synthesis.
引用
收藏
页码:412 / 418
页数:7
相关论文
共 50 条
  • [21] GH therapy does not alter the IGF-I/IGFBP-3 molar ratio in GH deficient (GHD) children.: Results from a 2-yrs prospective longitudinal study
    Scire, Giuseppe
    Del Bianco, Chiara
    Spadoni, Gian Luigi
    Cianfarani, Stefano
    HORMONE RESEARCH, 2006, 65 : 154 - 154
  • [22] Effect of acute elevation of IGF-I on circulating GH, TSH, insulin, IGF-II and IGFBP-3 levels in non-endocrine short stature (NESS)
    Hanew, K
    Tanaka, A
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2001, 24 (01) : 1 - 7
  • [23] Effect of acute elevation of IGF-I on circulating GH, TSH, insulin, IGF-II and IGFBP-3 levels in non-endocrine short stature (NESS)
    Hanew K.
    Tanaka A.
    Journal of Endocrinological Investigation, 2001, 24 (1) : 1 - 7
  • [24] IGF-I and IGFBP-3 concentrations related to stimulated GH following BMT.
    Cicognani, A
    Pession, A
    Pasini, A
    Boschi, S
    Alvisi, P
    De Iasio, R
    Mazzanti, L
    Paolucci, G
    Cacciari, E
    BONE MARROW TRANSPLANTATION, 1998, 21 : S161 - S161
  • [25] Monitoring serum insulin-like growth factor-I (IGF-I), IGF binding protein-3 (IGFBP-3), IGF-I/IGFBP-3 molar ratio and leptin during growth hormone treatment for disordered growth
    Tillmann, V
    Patel, L
    Gill, MS
    Whatmore, AJ
    Price, DA
    Kibirige, MS
    Wales, JK
    Clayton, PE
    CLINICAL ENDOCRINOLOGY, 2000, 53 (03) : 329 - 336
  • [26] A patient of short stature with normal GH secretion, but a low serum IGF-I level
    Mochizuki, D
    Kodama, H
    Kubota, K
    Mori, Y
    Nakamoto, N
    Kobayashi, M
    Yanagawa, Y
    Kaji, M
    ENDOCRINE JOURNAL, 2000, 47 : S125 - S127
  • [27] GROWTH-HORMONE (GH) TREATMENT INCREASES SERUM LEVELS OF IGF-I, IGF-II, IGFBP-3 AND IGFBP-5 IN CHILDREN WITH GH DEFICIENCY
    KANZAKI, S
    BAYLINK, DJ
    SEINO, Y
    MOHAN, S
    JOURNAL OF BONE AND MINERAL RESEARCH, 1995, 10 : S352 - S352
  • [28] Effect of zinc supplementation on growth hormone secretion, IGF-I, IGFBP-3, somatomedin generation, alkaline phosphatase, osteocalcin and growth in prepubertal children with idiopathic short stature
    Imamoglu, S
    Bereket, A
    Turan, S
    Haklar, G
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2005, 18 (01): : 69 - 74
  • [29] The effect of IGF-I and IGF-I/IGFBP-3 complex on osteoclastogenesis and osteoblastogenesis.
    Inoue, M
    Moriwake, T
    Tanaka, H
    Kanzaki, S
    Seino, Y
    JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 : S232 - S232
  • [30] IGF-I, IGFBP-3, and IGF-I/IGFBP-3 ratio: No association with incident colorectal cancer in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study
    Max, Joshua B.
    Limburg, Paul J.
    Ogunseitan, Adeboye
    Stolzenberg-Solomon, Rachael Z.
    Vierkant, Robert A.
    Pollak, Michael J.
    Sellers, Thomas A.
    Virtamo, Jarmo
    Cerhan, James R.
    Albanes, Demetrius
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2008, 17 (07) : 1832 - 1834